JP2023058515A5 - - Google Patents

Download PDF

Info

Publication number
JP2023058515A5
JP2023058515A5 JP2023006843A JP2023006843A JP2023058515A5 JP 2023058515 A5 JP2023058515 A5 JP 2023058515A5 JP 2023006843 A JP2023006843 A JP 2023006843A JP 2023006843 A JP2023006843 A JP 2023006843A JP 2023058515 A5 JP2023058515 A5 JP 2023058515A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023006843A
Other versions
JP2023058515A (ja
Filing date
Publication date
Priority claimed from KR1020180036190A external-priority patent/KR102340989B1/ko
Application filed filed Critical
Publication of JP2023058515A publication Critical patent/JP2023058515A/ja
Publication of JP2023058515A5 publication Critical patent/JP2023058515A5/ja
Pending legal-status Critical Current

Links

JP2023006843A 2018-03-28 2023-01-19 クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用 Pending JP2023058515A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2018-0036190 2018-03-28
KR1020180036190A KR102340989B1 (ko) 2018-03-28 2018-03-28 클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도
PCT/KR2019/003594 WO2019190206A1 (ko) 2018-03-28 2019-03-27 클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도
JP2020552830A JP7311530B2 (ja) 2018-03-28 2019-03-27 クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020552830A Division JP7311530B2 (ja) 2018-03-28 2019-03-27 クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用

Publications (2)

Publication Number Publication Date
JP2023058515A JP2023058515A (ja) 2023-04-25
JP2023058515A5 true JP2023058515A5 (ja) 2023-09-15

Family

ID=68060609

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020552830A Active JP7311530B2 (ja) 2018-03-28 2019-03-27 クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用
JP2023006843A Pending JP2023058515A (ja) 2018-03-28 2023-01-19 クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020552830A Active JP7311530B2 (ja) 2018-03-28 2019-03-27 クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用

Country Status (11)

Country Link
US (1) US20210115134A1 (ja)
EP (1) EP3778638A4 (ja)
JP (2) JP7311530B2 (ja)
KR (1) KR102340989B1 (ja)
CN (1) CN112204053A (ja)
AU (1) AU2019243255B2 (ja)
BR (1) BR112020019553A2 (ja)
CA (1) CA3095139A1 (ja)
MX (1) MX2020010082A (ja)
RU (1) RU2768002C1 (ja)
WO (1) WO2019190206A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210037581A (ko) * 2019-09-26 2021-04-06 (재)록원바이오융합연구재단 항-클라우딘-3 키메라 항원 수용체
BR112023018987A2 (pt) * 2021-03-19 2023-12-05 Glaxosmithkline Ip Dev Ltd Receptores de antígenos quiméricos direcionados à claudina-3 e métodos de tratamento do câncer
CN114478802B (zh) * 2022-01-28 2023-05-26 郑州大学 一种嵌合抗原受体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
EP1790664A1 (en) * 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
AU2007332473B2 (en) * 2006-12-14 2012-09-27 Forerunner Pharma Research Co., Ltd. Anti-Claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
WO2009028663A1 (ja) * 2007-08-30 2009-03-05 Kyowa Hakko Kirin Co., Ltd. 抗Claudin-3抗体
CN107090043B (zh) * 2011-05-13 2021-12-07 加尼梅德药物公司 用于治疗表达密蛋白6之癌症的抗体
US9751941B2 (en) * 2013-03-14 2017-09-05 Abion Inc. Antigen derived from extracellular domain of multi-transmembrane protein and uses thereof
KR101782623B1 (ko) * 2013-07-10 2017-09-28 서울대학교산학협력단 복합 막횡단 단백질의 세포막외 펩타이드 항원 및 그의 용도
MX2016005763A (es) * 2013-11-06 2016-08-19 Stemcentrx Inc Anticuerpos anti-claudina novedosos y metodos de uso.
CN104548130A (zh) * 2014-09-16 2015-04-29 四川大学 一种干扰Claudin3 基因表达的靶向脂质体
SG11201708191XA (en) * 2015-04-08 2017-11-29 Novartis Ag Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car) - expressing cell
WO2016180468A1 (en) * 2015-05-11 2016-11-17 Biontech Cell & Gene Therapies Gmbh Claudin-18.2-specific immunoreceptors and t cell epitopes
KR20180036190A (ko) 2016-09-30 2018-04-09 양진홍 키워드 기반의 장면 인식 방법 및 시스템
KR102055936B1 (ko) * 2017-09-20 2019-12-16 에이비온 주식회사 클라우딘 3 및 4에 대한 단일클론항체 및 그의 용도

Similar Documents

Publication Publication Date Title
BR102023014872A2 (ja)
BR102023012440A2 (ja)
BR102023010976A2 (ja)
BR102023009641A2 (ja)
BR102023008688A2 (ja)
BR102023007252A2 (ja)
BR102023005164A2 (ja)
BR102023001987A2 (ja)
BR102023001877A2 (ja)
BR102023000289A2 (ja)
BR102022026909A2 (ja)
BR102022023461A2 (ja)
BR202022009269U2 (ja)
BR202022005961U2 (ja)
BR202022001779U2 (ja)
BR202022000931U2 (ja)
BY13142U (ja)
BY13151U (ja)
BY13136U (ja)
BY13137U (ja)
BY13138U (ja)
BY13139U (ja)
BY13140U (ja)
BY13141U (ja)
BY13158U (ja)